What is Iotamotion?
Iotamotion specializes in the development of advanced robotic-assisted technology designed to optimize cochlear implant surgery. The company's core innovation, the iotaSOFT Insertion System, addresses the inherent challenges of manual electrode array placement by providing surgeons with a controlled, gentle, and highly precise insertion process. By minimizing trauma to the delicate structures of the cochlea, Iotamotion aims to improve long-term auditory outcomes for patients suffering from severe hearing loss.
The firm operates at the intersection of robotics and otolaryngology, positioning itself as a vital player in the medical technology landscape. Its target market encompasses specialized surgical centers, hospitals, and healthcare providers seeking to reduce surgical variability and enhance patient recovery profiles. Through its focus on technological precision, Iotamotion is effectively lowering the barriers to entry for complex cochlear implantation procedures.
How much funding has Iotamotion raised?
Iotamotion has raised a total of $18.4M across 4 funding rounds:
Angel/Seed
$2M
Angel/Seed
$2.5M
Series A
$12M
Debt
$1.9M
Angel/Seed (2017): $2M with participation from Undisclosed
Angel/Seed (2019): $2.5M led by Undisclosed
Series A (2023): $12M supported by Mutual Capital Partners, Next Level Ventures, and ISA Ventures
Debt (2026): $1.9M, investors not publicly disclosed
Key Investors in Iotamotion
Mutual Capital Partners
A Cleveland-based venture capital fund that specializes in early-stage software and medical device companies, providing both financial support and strategic guidance to foster revenue growth.
Next Level Ventures
An Iowa-based investment firm managing over $400 million in assets, focusing on strategic partnerships and operational support for companies ranging from seed to growth-stage.
ISA Ventures
A multi-stage venture capital fund dedicated to supporting Iowa-based businesses in sectors like biotechnology and healthcare, facilitating growth through various stages of development.
What's next for Iotamotion?
With the successful closure of this major strategic investment, Iotamotion is poised to enter a phase of accelerated commercialization and clinical expansion. The company will likely prioritize the scaling of its manufacturing capabilities and the broadening of its distribution network to meet the growing demand for robotic-assisted surgical solutions. Furthermore, the infusion of capital will support ongoing research and development efforts, potentially leading to the next generation of surgical tools that further refine the standard of care in hearing restoration.
As Iotamotion transitions into this mature growth phase, the focus will shift toward securing broader regulatory approvals and establishing deeper partnerships with leading academic medical centers. By maintaining its commitment to surgical excellence and patient-centric innovation, the company is well-equipped to solidify its market position and drive long-term value for its stakeholders.
